A Clinical Study of Chronic Pancreatitis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chronic Pancreatitis. 2
Module "Fundamentals of diagnostics, treatment and prevention of major diseases of the digestive system" Practical training: "Chronic pancreatitis (CP)" Topicality The incidence of chronic pancreatitis is 4.8 new cases per 100 000 of population per year. Prevalence is 25 to 30 cases per 100 000 of population. Total number of patients with CP increased in the world by 2 times for the last 30 years. In Ukraine, the prevalence of diseases of the pancreas (CP) increased by 10.3%, and the incidence increased by 5.9%. True prevalence rate of CP is difficult to establish, because diagnosis is difficult, especially in initial stages. The average time of CP diagnosis ranges from 30 to 60 months depending on the etiology of the disease. Learning objectives: to teach students to recognize the main symptoms and syndromes of CP; to familiarize students with physical examination methods of CP; to familiarize students with study methods used for the diagnosis of CP, the determination of incretory and excretory pancreatic insufficiency, indications and contraindications for their use, methods of their execution, the diagnostic value of each of them; to teach students to interpret the results of conducted study; to teach students how to recognize and diagnose complications of CP; to teach students how to prescribe treatment for CP. What should a student know? Frequency of CP; Etiological factors of CP; Pathogenesis of CP; Main clinical syndromes of CP, CP classification; General and alarm symptoms of CP; Physical symptoms of CP; Methods of -
Hereditary Pancreatitis
Fact Sheet - Hereditary Pancreatitis Hereditary Pancreatitis (HP) is a rare genetic condition characterized by recurrent episodes of pancreatic attacks, which can progress to chronic pancreatitis. Symptoms include abdominal pain, nausea, and vomiting. Onset of attacks typically occurs between within the first two decades of life, but can begin at any age. In the United States, it is estimated that at least 1,000 individuals are affected with hereditary pancreatitis. HP has also been linked to an increased lifetime risk of pancreatic cancer. Pancreatic cancer is the 4th leading cause of cancer deaths among Americans. Individuals with hereditary pancreatitis appear to have a 40% lifetime risk of developing pancreatic cancer. This increased risk is heavily dependent upon the duration of chronic pancreatitis and environmental exposures to alcohol and smoking. One recent study suggested that individuals with chronic pancreatitis for more than 25 years had a higher rate of pancreatic cancer when compared to individuals in the general population. This increased rate appears to be due to the prolonged chronic pancreatitis rather than having a gene mutation (all cationic trypsinogen mutations). It is important to note that these risk values may be higher than expected because these studies on pancreatic cancer use a highly selective population rather than a randomly selected population. At this time, there is no cure for HP. Treating the symptoms associated with HP is the choice method of medical management. Patients may be prescribed pancreatic enzyme supplements to treat maldigestion, insulin to treat diabetes, analgesics and narcotics to control pain, and lifestyle changes to reduce the risk of pancreatic cancer (for example, NO SMOKING!). -
Pancreatic Disorders in Inflammatory Bowel Disease
Submit a Manuscript: http://www.wjgnet.com/esps/ World J Gastrointest Pathophysiol 2016 August 15; 7(3): 276-282 Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx ISSN 2150-5330 (online) DOI: 10.4291/wjgp.v7.i3.276 © 2016 Baishideng Publishing Group Inc. All rights reserved. MINIREVIEWS Pancreatic disorders in inflammatory bowel disease Filippo Antonini, Raffaele Pezzilli, Lucia Angelelli, Giampiero Macarri Filippo Antonini, Giampiero Macarri, Department of Gastro- acute pancreatitis or chronic pancreatitis has been rec enterology, A.Murri Hospital, Polytechnic University of Marche, orded in patients with inflammatory bowel disease (IBD) 63900 Fermo, Italy compared to the general population. Although most of the pancreatitis in patients with IBD seem to be related to Raffaele Pezzilli, Department of Digestive Diseases and Internal biliary lithiasis or drug induced, in some cases pancreatitis Medicine, Sant’Orsola-Malpighi Hospital, 40138 Bologna, Italy were defined as idiopathic, suggesting a direct pancreatic Lucia Angelelli, Medical Oncology, Mazzoni Hospital, 63100 damage in IBD. Pancreatitis and IBD may have similar Ascoli Piceno, Italy presentation therefore a pancreatic disease could not be recognized in patients with Crohn’s disease and ulcerative Author contributions: Antonini F designed the research; Antonini colitis. This review will discuss the most common F and Pezzilli R did the data collection and analyzed the data; pancreatic diseases seen in patients with IBD. Antonini F, Pezzilli R and Angelelli L wrote the paper; Macarri G revised the paper and granted the final approval. Key words: Pancreas; Pancreatitis; Extraintestinal mani festations; Exocrine pancreatic insufficiency; Ulcerative Conflictofinterest statement: The authors declare no conflict colitis; Crohn’s disease; Inflammatory bowel disease of interest. -
Idiopathic and Hereditary Pancreatitis Testing
Idiopathic and Hereditary Pancreatitis Testing Pancreatitis is a relatively common disorder with multiple etiologies that causes inammation in the pancreas. Acute pancreatitis (AP) is a result of sudden inammation, and patients may present with increased pancreatic enzyme concentrations. Chronic Tests to Consider pancreatitis (CP) is a syndrome of progressive inammation that may lead to permanent damage to pancreatic structure and function. Genetic testing can be utilized to determine Pancreatitis, Panel (CFTR, CTRC, PRSS1, a genetic cause of idiopathic or hereditary AP or CP and/or to assess risk of disease in SPINK1) Sequencing (Temporary Referral as of 12/7/20) 2010876 family members. Method: Polymerase Chain Reaction/Sequencing Preferred test for individuals with history of Disease Overview idiopathic pancreatitis Pancreatitis (CTRC) Sequencing 2010703 Incidence/Prevalence Method: Polymerase Chain Reaction/Sequencing Chronic pancreatitis For adults with idiopathic pancreatitis if other components of panel (CFTR , PRSS1 , SPINK1 ) Incidence: ~4-12/100,000 per year 1 have been sequenced without providing a Prevalence: ~37-42/100,000 1 complete explanation for the pancreatitis Idiopathic chronic pancreatitis is more common than previously thought 2 Pancreatitis (PRSS1) Sequencing and Deletion/Duplication (Temporary Referral Symptoms/Presentation Etiologies as of 01/14/21) 3001768 Method: Polymerase Chain Reaction/Sequencing Acute Sudden onset of pain in Common and Multiplex Ligation Dependent Probe Amplic- pancreatitis the upper abdomen, -
Hereditary Pancreatitis: Outcomes and Risks
HEREDITARY PANCREATITIS: OUTCOMES AND RISKS by Celeste Alexandra Shelton BS, University of Pittsburgh, 2013 Submitted to the Graduate Faculty of the Graduate School of Public Health in partial fulfillment of the requirements for the degree of Master of Science University of Pittsburgh 2015 UNIVERSITY OF PITTSBURGH Graduate School of Public Health This thesis was presented by Celeste Alexandra Shelton It was defended on April 7, 2015 and approved by Thesis Director David C. Whitcomb, MD, PhD, Chief, Division of Gastroenterology, Hepatology and Nutrition, Giant Eagle Foundation Professor of Cancer Genetics, Professor of Medicine, Cell Biology & Physiology and Human Genetics, School of Medicine, University of Pittsburgh Committee Members Randall E. Brand, MD, Professor of Medicine, School of Medicine, University of Pittsburgh, Academic Director, GI-Division, UPMC Shadyside, Dir., GI Malignancy Early Detection, Diagnosis & Prevention Program, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Robin E. Grubs, PhD, LCGC, Assistant Professor, Director, Genetic Counseling Program, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh John R. Shaffer, PhD, Assistant Professor, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh ii Copyright © by Celeste Shelton 2015 iii HEREDITARY PANCREATITIS: OUTCOMES AND RISKS Celeste A. Shelton, MS University of Pittsburgh, 2015 ABSTRACT Pancreatitis is an inflammatory disease of the pancreas that was first identified in the 1600s. Symptoms for pancreatitis include intense abdominal pain, nausea, and malnutrition. Hereditary pancreatitis (HP) is a genetic condition in which recurrent acute attacks can progress to chronic pancreatitis, typically beginning in adolescence. Mutations in the PRSS1 gene cause autosomal dominant HP. -
ESPEN Guideline on Clinical Nutrition in Acute and Chronic Pancreatitis
Clinical Nutrition 39 (2020) 612e631 Contents lists available at ScienceDirect Clinical Nutrition journal homepage: http://www.elsevier.com/locate/clnu ESPEN Guideline ESPEN guideline on clinical nutrition in acute and chronic pancreatitis * Marianna Arvanitakis a, , Johann Ockenga b, Mihailo Bezmarevic c, Luca Gianotti d, , Zeljko Krznaric e, Dileep N. Lobo f g, Christian Loser€ h, Christian Madl i, Remy Meier j, Mary Phillips k, Henrik Højgaard Rasmussen l, Jeanin E. Van Hooft m, Stephan C. Bischoff n a Department of Gastroenterology, Erasme University Hospital ULB, Brussels, Belgium b Department of Gastroenterology, Endocrinology and Clinical Nutrition, Klinikum Bremen Mitte, Bremen, Germany c Department of Hepatobiliary and Pancreatic Surgery, Clinic for General Surgery, Military Medical Academy, University of Defense, Belgrade, Serbia d School of Medicine and Surgery, University of Milano-Bicocca and Department of Surgery, San Gerardo Hospital, Monza, Italy e Department of Gastroenterology, Hepatology and Nutrition, Clinical Hospital Centre & School of Medicine, Zagreb, Croatia f Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research. (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK g MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK h Medical Clinic, DRK-Kliniken -
Prevalence of Pancreatitis in Female and Male Pediatric Patients in Eastern Kentucky in the United States
Central Journal of Family Medicine & Community Health Research Article *Corresponding author Karin N. Westlund, Department of Physiology, University of Kentucky, MS-508 Medical Science Building, 800 Prevalence of Pancreatitis in Rose, Lexington, KY, 40536-0298, USA, Tel: 859-323-0672 or -33668; Email: Submitted: 23 August 2016 Female and Male Pediatric Accepted: 10 November 2016 Published: 12 November 2016 Patients in Eastern Kentucky in ISSN: 2379-0547 Copyright the United States © 2016 Westlund et al. OPEN ACCESS Sabrina L. McIlwrath and Karin N. Westlund* Department of Physiology, University of Kentucky, USA Keywords • Epidemiology • Gender difference Abstract • Recurrent acute pancreatitis Background & aims: Studies in the past decade report worldwide increase of • Tobacco use pediatric pancreatitis. The present study focuses on aUnited States region where the • Obesity first genes associated with hereditary pancreatitis were identified. Aim of the study was to investigate incidences of acute pancreatitis, recurrent acute pancreatitis, and chronic pancreatitis, collecting demographics, etiologies, and comorbid conditions using charted ICD-9-CM codes. Methods: Retrospective chart review was performed on de-identified patient records of hospitalizations at University of Kentucky hospitals between 2005 and 2013. Results: Of 234 children diagnosed during the 9 year time period, 69.2% (n=162) had a single episode of acute, 27.8% (65) recurrent acute, and 16.2% (38) chronic pancreatitis. Surprisingly, the annual incidence for first time diagnosis of acute pancreatitis was significantly higher for female patients (16.1, 95% CI: 13.5- 18.7 per 100,000, P<0.005) compared to males (9.1, 95% CI: 6.8-11.4). Comorbid conditions varied widely depending on patients’ age. -
Clinical Biliary Tract and Pancreatic Disease
Clinical Upper Gastrointestinal Disorders in Urgent Care, Part 2: Biliary Tract and Pancreatic Disease Urgent message: Upper abdominal pain is a common presentation in urgent care practice. Narrowing the differential diagnosis is sometimes difficult. Understanding the pathophysiology of each disease is the key to making the correct diagnosis and providing the proper treatment. TRACEY Q. DAVIDOFF, MD art 1 of this series focused on disorders of the stom- Pach—gastritis and peptic ulcer disease—on the left side of the upper abdomen. This article focuses on the right side and center of the upper abdomen: biliary tract dis- ease and pancreatitis (Figure 1). Because these diseases are regularly encountered in the urgent care center, the urgent care provider must have a thorough understand- ing of them. Biliary Tract Disease The gallbladder’s main function is to concentrate bile by the absorption of water and sodium. Fasting retains and concentrates bile, and it is secreted into the duodenum by eating. Impaired gallbladder contraction is seen in pregnancy, obesity, rapid weight loss, diabetes mellitus, and patients receiving total parenteral nutrition (TPN). About 10% to 15% of residents of developed nations will form gallstones in their lifetime.1 In the United States, approximately 6% of men and 9% of women 2 have gallstones. Stones form when there is an imbal- ©Phototake.com ance in the chemical constituents of bile, resulting in precipitation of one or more of the components. It is unclear why this occurs in some patients and not others, Tracey Q. Davidoff, MD, is an urgent care physician at Accelcare Medical Urgent Care in Rochester, New York, is on the Board of Directors of the although risk factors do exist. -
Genetic Testing for Hereditary Pancreatitis
Genetic Testing for Hereditary Pancreatitis Last Review Date: October 12, 2018 Number: MG.MM.LA.28C3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth the clinical evidence that the patient meets the criteria for the treatment or surgical procedure. Without this documentation and information, EmblemHealth will not be able to properly review the request for prior authorization. The clinical review criteria expressed below reflects how EmblemHealth determines whether certain services or supplies are medically necessary. EmblemHealth established the clinical review criteria based upon a review of currently available clinical information (including clinical outcome studies in the peer-reviewed published medical literature, regulatory status of the technology, evidence-based guidelines of public health and health research agencies, evidence- based guidelines and positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas, and other relevant factors). EmblemHealth expressly reserves the right to revise these conclusions as clinical information changes, and welcomes further relevant information. Each benefit program defines which services are covered. The conclusion that a particular service or supply is medically necessary does not constitute a representation or warranty that this service or supply is covered and/or paid for by EmblemHealth, as some programs exclude coverage for services or supplies that EmblemHealth considers medically necessary. If there is a discrepancy between this guideline and a member's benefits program, the benefits program will govern. In addition, coverage may be mandated by applicable legal requirements of a state, the Federal Government or the Centers for Medicare & Medicaid Services (CMS) for Medicare and Medicaid members. -
Abdominal Pain
10 Abdominal Pain Adrian Miranda Acute abdominal pain is usually a self-limiting, benign condition that irritation, and lateralizes to one of four quadrants. Because of the is commonly caused by gastroenteritis, constipation, or a viral illness. relative localization of the noxious stimulation to the underlying The challenge is to identify children who require immediate evaluation peritoneum and the more anatomically specific and unilateral inner- for potentially life-threatening conditions. Chronic abdominal pain is vation (peripheral-nonautonomic nerves) of the peritoneum, it is also a common complaint in pediatric practices, as it comprises 2-4% usually easier to identify the precise anatomic location that is produc- of pediatric visits. At least 20% of children seek attention for chronic ing parietal pain (Fig. 10.2). abdominal pain by the age of 15 years. Up to 28% of children complain of abdominal pain at least once per week and only 2% seek medical ACUTE ABDOMINAL PAIN attention. The primary care physician, pediatrician, emergency physi- cian, and surgeon must be able to distinguish serious and potentially The clinician evaluating the child with abdominal pain of acute onset life-threatening diseases from more benign problems (Table 10.1). must decide quickly whether the child has a “surgical abdomen” (a Abdominal pain may be a single acute event (Tables 10.2 and 10.3), a serious medical problem necessitating treatment and admission to the recurring acute problem (as in abdominal migraine), or a chronic hospital) or a process that can be managed on an outpatient basis. problem (Table 10.4). The differential diagnosis is lengthy, differs from Even though surgical diagnoses are fewer than 10% of all causes of that in adults, and varies by age group. -
Chronic Pancreatitis
CHRONIC PANCREATITIS Chronic pancreatitis is an inflammatory pancreas disease with the development of parenchyma sclerosis, duct damage and changes in exocrine and endocrine function. The causes of chronic pancreatitis Alcohol; Diseases of the stomach, duodenum, gallbladder and biliary tract. With hypertension in the bile ducts of bile reflux into the ducts of the pancreas. Infection. Transition of infection from the bile duct to the pancreas, By the vessels of the lymphatic system, Medicinal. Long -term administration of sulfonamides, antibiotics, glucocorticosteroids, estrogens, immunosuppressors, diuretics and NSAIDs. Autoimmune disorders. Congenital disorders of the pancreas. Heredity; In the progression of chronic pancreatitis are playing important pathological changes in other organs of the digestive system. The main symptoms of an exacerbation of chronic pancreatitis: Attacks of pain in the epigastric region associated or not with a meal. Pain radiating to the back, neck, left shoulder; Inflammation of the head - the pain in the right upper quadrant, body - pain in the epigastric proper region, tail - a pain in the left upper quadrant. Pain does not subside after vomiting. The pain increases after hot-water bottle. Dyspeptic disorders, including flatulence, Malabsorption syndrome: Diarrhea (50%). Feces unformed, (steatorrhea, amylorea, creatorrhea). Weight loss. On examination, patients. Signs of hypovitaminosis (dry skin, brittle hair, nails, etc.), Hemorrhagic syndrome - a symptom of Gray-Turner (subcutaneous hemorrhage and cyanosis on the lateral surfaces of the abdomen or around the navel) Painful points in the pathology of the pancreas Point choledocho – pankreatic. Kacha point. The point between the outer and middle third of the left costal arch. The point of the left phrenic nerve. -
Prevalence of Pancreatic Insufficiency in Inflammatory Bowel Diseases
Dig Dis Sci DOI 10.1007/s10620-007-9852-y ORIGINAL PAPER Prevalence of Pancreatic Insufficiency in Inflammatory Bowel Diseases. Assessment by Fecal Elastase-1 Giovanni Maconi Æ Roberto Dominici Æ Mirko Molteni Æ Sandro Ardizzone Æ Matteo Bosani Æ Elisa Ferrara Æ Silvano Gallus Æ Mauro Panteghini Æ Gabriele Bianchi Porro Received: 16 December 2005 / Accepted: 1 March 2006 Ó Springer Science+Business Media, LLC 2007 Abstract Pancreatic insufficiency (PI) may be an extra- At the 6-month follow-up, FE-1 values became normal in intestinal manifestation of inflammatory bowel diseases 24 patients and showed persistently low concentrations in (IBD). We report the results of a cross-sectional study that 12. These patients had a larger number of bowel move- was carried out to investigate both the prevalence of PI in ments per day (OR = 5.4), previous surgery (OR = 5.7), IBD patients and its clinical course over a 6-month follow- and a longer duration of the disease (OR = 4.2). PI is up period. In total, 100 Crohn’s disease (CD) patients, 100 frequently found in IBD patients, particularly in those with ulcerative colitis (UC) patients, and 100 controls were loose stools, a larger number of bowel movements/day and screened for PI by the fecal elastase-1 (FE-1) test. The previous surgery. PI is reversible in most patients, and decision limits employed were: £ 200 lg/g stool for PI persistent PI is not associated with clinically active disease. and £ 100 lg/g for severe PI. Patients with abnormal FE-1 values were re-tested after 6 months.